Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleHuman Study

Dosimetry of Rhenium-186-Labeled Monoclonal Antibodies: Methods, Prediction from Technetium-99m-Labeled Antibodies and Results of Phase I Trials

Hazel B. Breitz, Darrell R. Fisher, Paul L. Weiden, James S. Durham, Barbara A. Ratliff, Michael J. Bjorn, Paul L. Beaumier and Paul G. Abrams
Journal of Nuclear Medicine June 1993, 34 (6) 908-917;
Hazel B. Breitz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darrell R. Fisher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul L. Weiden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James S. Durham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara A. Ratliff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Bjorn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul L. Beaumier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul G. Abrams
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 34, Issue 6
June 1, 1993
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dosimetry of Rhenium-186-Labeled Monoclonal Antibodies: Methods, Prediction from Technetium-99m-Labeled Antibodies and Results of Phase I Trials
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Dosimetry of Rhenium-186-Labeled Monoclonal Antibodies: Methods, Prediction from Technetium-99m-Labeled Antibodies and Results of Phase I Trials
Hazel B. Breitz, Darrell R. Fisher, Paul L. Weiden, James S. Durham, Barbara A. Ratliff, Michael J. Bjorn, Paul L. Beaumier, Paul G. Abrams
Journal of Nuclear Medicine Jun 1993, 34 (6) 908-917;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Dosimetry of Rhenium-186-Labeled Monoclonal Antibodies: Methods, Prediction from Technetium-99m-Labeled Antibodies and Results of Phase I Trials
Hazel B. Breitz, Darrell R. Fisher, Paul L. Weiden, James S. Durham, Barbara A. Ratliff, Michael J. Bjorn, Paul L. Beaumier, Paul G. Abrams
Journal of Nuclear Medicine Jun 1993, 34 (6) 908-917;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Enhanced Therapeutic Index of Radioimmunotherapy (RIT) in Prostate Cancer Patients: Comparison of Radiation Dosimetry for 1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-Tetraacetic Acid (DOTA)-Peptide versus 2IT-DOTA Monoclonal Antibody Linkage for RIT
  • Two-Step Targeting of Xenografted Colon Carcinoma Using a Bispecific Antibody and 188Re-Labeled Bivalent Hapten: Biodistribution and Dosimetry Studies
  • Phase I Therapy Study of 186Re-Labeled Chimeric Monoclonal Antibody U36 in Patients with Squamous Cell Carcinoma of the Head and Neck
  • How Far Have We Come with Solid (Nonhematologic) Tumor Radioimmunotherapy?
  • Google Scholar

More in this TOC Section

  • New Treatment Approaches to Liver Tumors
  • Indium-111-Pentetreotide Uptake in Endocrine Tumors and Lymphoma
  • Lymphatic Drainage to Triangular Intermuscular Space Lymph Nodes in Melanoma on the Back
Show more Human Study

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire